2019 Health for Humanity Report
Windmills in the water off of coast of Belgium and Netherlands
Windmills in the water off of coast of Belgium and Netherlands

© Norther wind farm off the coast of Belgium and the Netherlands provides renewable energy for our operations in both countries.

Environmental Health
Environmental Health Product Sustainability
  • HC-MS-410a.2
    Total amount of products accepted for takeback and reused, recycled, or donated, broken down by: (1) devices and equipment and (2)supplies

Products in the Environment

We recognize that the products we create to help patients, doctors and consumers can continue to have environmental impacts after use. Whether the product is metabolized and excreted, or used and discarded, these actions can have environmental impacts. We have a diverse portfolio of products and services that have unique impacts at end of life. Therefore, we assess the end-of-life impacts of our products and develop category-specific action plans to improve performance over time. See our Position on Impact of Pharmaceuticals and Personal Care Products in the Environment.

Pharmaceutical Products: We continue our work to reduce the impact of pharmaceuticals in the environment (PIE). In 2019, we completed a multi-year comprehensive assessment of PIE for 100% of our current pharmaceutical suppliers located in India and China. We have also reported our progress on working specifically with antibiotics producers globally through the Access to Medicine Foundation report on antibiotics, and the International Federation of Pharmaceutical Manufacturers & Associations report on antibiotics.

As an active and founding member of the Pharmaceutical Supply Chain Initiative, we helped build the capacity of suppliers by leading two PIE training sessions in 2019. As an active and founding member of the AMR Alliance, we contributed to the peer-reviewed publication of a new methodology to determine safe levels of antibiotics in the environment, which protects against formation of antibiotic resistance. The safe levels we contributed for this publication are for Johnson & Johnson’s antibiotics. As a group, the AMR Alliance Manufacturing Work Group achieved their original four goals aimed at assessing risk, developing an assessment framework, advancing science, and reporting transparently a year early. For additional information on our work on antimicrobial resistance see the section on Overcoming Antimicrobial Resistance.

Medical Devices: We comply with applicable Extended Producer Responsibility regulations in different countries and invest in many initiatives for better management of our products at end of life. We support voluntary take-back programs, and we work with our customers to evaluate opportunities to increase the number and quantity of products that can be recycled and reprocessed. For example, the Johnson & Johnson Medical Devices Companies work with health facilities to collect medical devices that otherwise would be immediately bound for landfills or incineration, and reprocess those devices so that they can be reused by healthcare professionals.

  • 2.5 million
    medical devices collected and
  • 1.1 million
    reprocessed in 2019

Back To Sustainable Packaging & Recycling Up Next About this Report
You are leaving jnj.com and entering a third-party site. This link is provided for your convenience, and Johnson & Johnson disclaims liability for content created or maintained by third parties.